Carbamic Acid

Carbamic Acid

SCHEMBL27675461

Cc1ccc(F)c2c1CCN(S(=O)(=O)c1ccc(Oc3ccc(Cl)cc3)cc1)C2.NC(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
FAAH O00519 1/20 0.41
MGLL Q99685 1/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 3/20 0.40
LMNA P02545 3/20 0.40
MEN1 O00255 2/20 0.40
MMP8 P22894 2/20 0.39
MMP3 P08254 1/20 0.39
PKM P14618 3/20 0.39
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
MKNK1 Q9BUB5 2/20 0.39
HTT P42858 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
CTSG P08311 1/20 0.38
CMA1 P23946 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL27675445 0.77 AKR1C3 (0.61) MAPTKMT2AMEN1MMP8MMP3
SCHEMBL14427240 0.75 MMP8 (0.43) MAPTFAAHMGLLLMNAMMP8
SCHEMBL5435633 0.75 MMP8 (0.41) MAPTFAAHMGLLPOLBMMP8
SCHEMBL5437193 0.75 MMP8 (0.41) MAPTFAAHMGLLPOLBMMP8
SCHEMBL5439634 0.75 MMP8 (0.41) MAPTFAAHMGLLPOLBMMP8
SCHEMBL27675438 0.74 MMP9 (0.43) MAPTMMP8MMP3BCL2L1MCL1
SCHEMBL27693820 0.74 MMP9 (0.43) MAPTMMP8MMP3BCL2L1MCL1
SCHEMBL27675460 0.74 MMP9 (0.43) MAPTMMP8MMP3BCL2L1MCL1
SCHEMBL14427239 0.71 MMP1 (0.51) MMP8MMP3
Carbamic Acid SCHEMBL27693832 0.70 KMT2A (0.73) MAPTKMT2AMEN1PKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101006059-A Substituted tetrahydroisoquinolines for use as MMP inhibitors, method for the production thereof, and use thereof in the form of medicaments SANOFI AVENTIS DEUTSCHLAND (DE) 2007-07-25 CN disclosed